Literature DB >> 19219684

Expression of macrophage colony-stimulating factor (M-CSF) and its receptor in streptozotocin-induced diabetic rats.

Wei Liu1, Ge-zhi Xu, Chun-hui Jiang, Cui-di Da.   

Abstract

PURPOSE: To demonstrate the expression and location of macrophage colony-stimulating factor (M-CSF) and its receptor (CSF-1R) in the retinas of diabetic rats, as well as in vitreous human proliferative diabetic retinopathy (PDR).
METHODS: The retinas of streptozotocin-induced diabetic rat were studied. Real-time PCR was applied to evaluate M-CSF and its receptor CSF-1R mRNA expression in the retinas. The protein levels of M-CSF and CSF-1R were evaluated by Western blot analysis. Cellular sources of M-CSF and CSF-1R were determined by double-immunofluorescence staining. M-CSF levels in vitreous samples from patients with PDR were measured by ELISA.
RESULTS: M-CSF and CSF-1R mRNA were upregulated in the retinas as early as two weeks after the onset of diabetes and increased over time. A similar pattern was observed for M-CSF/CSF-1R protein expression levels. Double-immunofluorescence staining revealed that increased M-CSF immunoreactivity occurred mainly in the nerve fiber layer in diabetic retinas, co-localizing with glial fibrillary acidic protein. Increased CSF-1R immunoreactivity was observed in OX-42-labeled microglia and ganglion cells in the ganglion cell layer. The vitreous level of M-CSF was elevated in patients with PDR compared to control subjects.
CONCLUSIONS: The early upregulation of MCSF/CSF-1R signaling may be an important regulatory pathway among neurons, microglia, and glia in diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219684     DOI: 10.1080/02713680802650369

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.

Authors:  Ahmed S Ibrahim; Mamdouh M El-Shishtawy; Wenbo Zhang; Ruth B Caldwell; Gregory I Liou
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

3.  Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy.

Authors:  Modesto A Rojas; Zu T Shen; Ruth B Caldwell; Alexander B Sigalov
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-03       Impact factor: 5.187

4.  Role of adenosine in diabetic retinopathy.

Authors:  Gregory I Liou; Saif Ahmad; Mohammad Naime; Nadeem Fatteh; Ahmed S Ibrahim
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-11

5.  Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro.

Authors:  Wei Liu; Ge Z Xu; Chun H Jiang; Jie Tian
Journal:  BMC Cell Biol       Date:  2011-01-25       Impact factor: 4.241

6.  Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.

Authors:  Ahmed S Ibrahim; Azza B El-Remessy; Suraporn Matragoon; Wenbo Zhang; Yogin Patel; Sohail Khan; Mohammed M Al-Gayyar; Mamdouh M El-Shishtawy; Gregory I Liou
Journal:  Diabetes       Date:  2011-02-11       Impact factor: 9.461

Review 7.  Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.

Authors:  Alexander B Sigalov
Journal:  Adv Protein Chem Struct Biol       Date:  2017-07-24       Impact factor: 3.507

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.